TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 110 filers reported holding TRANSMEDICS GROUP INC in Q1 2021. The put-call ratio across all filers is 3.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $100,138 | -31.2% | 1,829 | +5.5% | 0.01% | -28.6% |
Q2 2023 | $145,537 | +28.2% | 1,733 | -5.8% | 0.01% | +40.0% |
Q4 2022 | $113,565 | +47.9% | 1,840 | 0.0% | 0.01% | +25.0% |
Q3 2022 | $76,802 | +32.7% | 1,840 | 0.0% | 0.00% | +33.3% |
Q2 2022 | $57,868 | +16.7% | 1,840 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $49,570 | -68.2% | 1,840 | -77.4% | 0.00% | 0.0% |
Q4 2021 | $156,097 | -42.1% | 8,147 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $269,584 | -15.6% | 8,147 | +5.8% | 0.00% | -20.0% |
Q1 2021 | $319,390 | +98.0% | 7,698 | -5.0% | 0.01% | +150.0% |
Q4 2020 | $161,290 | +44.4% | 8,105 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $111,687 | +4.0% | 8,105 | +35.2% | 0.00% | 0.0% |
Q2 2020 | $107,430 | +68.6% | 5,995 | +13.6% | 0.00% | +100.0% |
Q1 2020 | $63,722 | -36.5% | 5,275 | 0.0% | 0.00% | -50.0% |
Q4 2019 | $100,278 | – | 5,275 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Roubaix Capital, LLC | 264,438 | $5,027,000 | 4.84% |
Abrams Capital Management | 3,499,859 | $66,532,000 | 2.07% |
Sandhill Capital Partners LLC | 736,175 | $13,995,000 | 1.55% |
EMERALD ADVISERS, LLC | 451,542 | $8,584,000 | 0.36% |
RTW INVESTMENTS, LP | 503,266 | $9,567,000 | 0.36% |
EMERALD MUTUAL FUND ADVISERS TRUST | 429,868 | $8,172,000 | 0.33% |
NEXT CENTURY GROWTH INVESTORS LLC | 107,045 | $2,034,000 | 0.26% |
ELEMENT CAPITAL MANAGEMENT LLC | 63,175 | $1,201,000 | 0.26% |
HAMILTON LANE ADVISORS LLC | 19,364 | $368,000 | 0.16% |
Harbour Capital Advisors, LLC | 20,900 | $397,000 | 0.15% |